Back to Agenda
Session 8 Track 1: Hot Topics
Session Chair(s)
Amy Van Sant, PHARMD, MBA
President, Medical Affairs, Inizio Engage, United States
Our environment is constantly changing, and companies face increasing challenges to deliver high-quality and impactful medical communications. This session will touch on three ‘hot topics’ trending in the industry that may shape how we work in the future. Guest speakers will review some of the cutting edge work they are doing around these hot topics. The format of this session will be informal and audience questions are encouraged.
Learning Objective : At the conclusion of this session, participants should be able to:
- Discuss the complexities, challenges and successes in medical communications in light of FDA Guidance impacting medical communications
- Examine on a global level the impact of health equity
- Describe the impact of medical communications under an Emergency Use Authorizations (EUA)
- Identify emerging trends and their impact on Medical Communications
Speaker(s)
Hira Shah, PHARMD
Senior Director Regulatory Advertising and Promotion , Regeneron Pharmaceuticals, Inc, United States
FDA Guidance
Stephanie Young Moss, PHARMD, MS
Pharmacist, Owner, Integrative Pharmacy Outcomes and Consulting, United States
Health Equity
Constance Stangarone
Convention Services, Principal Manager, Genentech, United States
Virtual Congresses
Have an account?